These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 777029

  • 1. Defective neutrophil chemotaxis in bone marrow transplant patients.
    Clark RA, Johnson FL, Klebanoff SJ, Thomas ED.
    J Clin Invest; 1976 Jul; 58(1):22-31. PubMed ID: 777029
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Jul; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P.
    Cancer J Sci Am; 1996 Jul; 2(6):330-4. PubMed ID: 9166553
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [Abstract] [Full Text] [Related]

  • 5. Abnormal neutrophil chemotaxis in bone marrow transplant patients correlates with impaired 31D8 monoclonal antibody binding.
    Capsoni F, Minonzio F, Carbonelli V, Ongari AM, Mocellin MC, Soligo D, Annaloro C, Della Volpe A, Lambertenghi Dliliers G.
    Haematologica; 1995 Jul; 80(2):123-9. PubMed ID: 7628750
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD.
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [Abstract] [Full Text] [Related]

  • 8. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
    Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH, Ramsay NK.
    Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
    Ayuk F, Perez-Simon JA, Shimoni A, Sureda A, Zabelina T, Schwerdtfeger R, Martino R, Sayer HG, Alegre A, Lahuerta JJ, Atanackovic D, Wolschke C, Nagler A, Zander AR, San Miguel JF, Kröger N.
    Haematologica; 2008 Sep; 93(9):1343-50. PubMed ID: 18641030
    [Abstract] [Full Text] [Related]

  • 10. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K, Downs K, Ashby M, Dodds A, Concannon A, Biggs J.
    Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
    [Abstract] [Full Text] [Related]

  • 11. Marrow transplantation in aplastic anemia and leukemia.
    Weiden PL, Thomas ED, Storb R, Fefer A, Neiman PE, Clift RA, Buckner CD, Lerner KG.
    Compr Ther; 1976 Apr; 2(4):57-62. PubMed ID: 4261
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N, Zabelina T, Renges H, Krüger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuk F, Erttmann R, Kabisch H, Zander AR.
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia).
    Labar B, Bogdanic V, Kastelan A, Vrtar M, Grgic-Markulin L, Balabanic-Kamauf B, Francetic I, Dobric I, Grgicevic D, Kerhin-Brkljacic V.
    Biomed Pharmacother; 1986 Nov; 40(9):332-7. PubMed ID: 3548836
    [Abstract] [Full Text] [Related]

  • 15. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N, Sawada H, Hanada M, Shibata T, Tabata N, Watanabe M, Shimono Y, Deguchi T, Umemoto M, Higashikawa M, Kawasaki H, Komada Y, Sakurai M.
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [Abstract] [Full Text] [Related]

  • 16. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R, Van Riet I, Ben Othman T, Trullemans F, De Waele M, Van Camp B.
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [Abstract] [Full Text] [Related]

  • 17. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D.
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [Abstract] [Full Text] [Related]

  • 18. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N, Badsberg JH, Lönnqvist B, Ringdén O, Volin L, Rajantie J, Nikoskelainen J, Keiding N.
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [Abstract] [Full Text] [Related]

  • 19. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T, Masaoka T, Shibata H.
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [Abstract] [Full Text] [Related]

  • 20. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K, Lamia T, Amel L, Abdelrahmen A, Saloua L, Hana E, Amine S, Bechir Z, Tarek BO, Assia BH.
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.